Biopharma Healthcare Provider Leads Pharmaceutical manufacturing 
Clarivate
MARCH 14, 2024
Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt.
European Pharmaceutical Review
DECEMBER 21, 2022
The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure. Defossilization of pharmaceutical manufacturing.
Expert insights. Personalized for you.
52 
Let's personalize your content